RxDoctor Payments DataLook up a doctor →

Charles Bulfinch, DO

Family Medicine · Union Gap, WANPI 1104181221

Payments from drug & device makers

$16,119in general payments, 2019–2025

Across 950 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • AbbVie$2K
  • Pfizer$1K
  • GSK$1K
  • Novo Nordisk$1K
  • Boehringer Ingelheim$894
  • plus $7K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)114$2,969
AbbVie(2 entities)130$1,720
Pfizer101$1,454
GSK89$1,182
Novo Nordisk102$1,134
Boehringer Ingelheim40$894
Bayer33$585
Astellas Pharma US Inc14$470
Amgen(2 entities)35$464
Xeris Pharmaceuticals, Inc.25$450
Johnson & Johnson20$400
Abbott19$364
Novartis15$320
Sanofi-aventis U.S. LLC14$305
Takeda Pharmaceuticals U.S.A., Inc.13$292
Biohaven Pharmaceuticals, Inc.15$216
Sumitomo Pharma America, Inc.10$196
Biohaven Pharmaceutical Holding Company Ltd.14$196
Daiichi Sankyo Inc.9$187
Lilly USA, LLC11$181
Exact Sciences9$181
Corcept Therapeutics15$177
Otsuka America Pharmaceutical, Inc.9$175
Supernus Pharmaceuticals, Inc.12$167
Sunovion Pharmaceuticals Inc.11$166
Lundbeck LLC7$128
E.r. Squibb & Sons, L.L.C.7$127
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$77
Teva Pharmaceuticals USA, Inc.2$58
Electromed, Inc.1$57
Esperion Therapeutics, Inc.3$55
Mylan Specialty L.p.3$52
Alnylam Pharmaceuticals Inc.3$50
Viiv Healthcare Company2$46
Inspire Medical Systems, Inc.1$42
Amarin Pharma, Inc.2$40
Axsome Therapeutics, Inc.2$39
Eisai Inc.2$39
Vanda Pharmaceuticals Inc.2$38
Echosens North America, Inc.3$34
Chiesi USA, Inc.2$34
Dexcom, Inc.1$29
Kowa Pharmaceuticals America, Inc.2$26
Recordati_rare_diseases_inc.1$26
Phathom Pharmaceuticals, Inc.3$26
Urovant Sciences Inc1$25
Radius Health, Inc.2$25
Neurocrine Biosciences, Inc.1$19
Merck1$18
Genentech USA, Inc.1$18
Phadia US Inc.1$18
Bristol Myers Squibb1$17
Sanofi Pasteur Inc.1$17
Biowound Solutions, Inc.2$17
Ironwood Pharmaceuticals, Inc1$15
Viatris Specialty LLC1$14
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$13
Alfasigma USA, Inc.1$13
Hologic Sales And Service, LLC1$13
Shire North American Group Inc1$11

How this compares

$16,119 in reported general payments places this provider in the 95th percentile of 2,275 family medicine providers in Washington.

See all family medicine providers in Washington →

Medicare billing

Part B allowed, 2024
$662
Medicare patients
37
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Union Gap

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →